Group 1 - Yong'an Pharmaceutical announced that its stock price has significantly increased recently, leading to a high risk of speculation, although there are no major changes in the company's fundamentals [3] - *ST Tongzhou will lift the delisting risk warning and other risk warnings starting June 17, with the stock name changing from "*ST Tongzhou" to "Tongzhou Electronics" and the daily price fluctuation limit changing to 10% [4] - Guangsheng Pharmaceutical's subsidiary received ethical review approval for a Phase III clinical trial of its innovative hepatitis B treatment, GST-HG141, which will be led by a prominent researcher [5] - Huahai Pharmaceutical received a drug registration certificate for its sustained-release formulation of fumaric acid quetiapine, aimed at treating schizophrenia and bipolar disorder [6] - Bozhong Precision plans to acquire 70% of Shanghai Wodian for 420 million yuan, aiming to enter the automotive intelligent equipment market [7] Group 2 - Baoli International's shareholder plans to reduce his stake by up to 3%, equating to a maximum of 27.468 million shares [9] - Guomao Co., Ltd.'s actual controllers intend to collectively reduce their holdings by up to 3%, totaling a maximum of 19.7726 million shares [10] - Heng Rui Pharmaceutical's director plans to reduce his holdings by up to 47,670 shares, representing 0.007% of the total share capital [11] - Shandong Zhanggu's directors and executives plan to collectively reduce their holdings by up to 155,080 shares, accounting for 0.5% of the total share capital [12] - Den Precision's executives plan to reduce their holdings by up to 29,550 shares, which is 0.2% of the total share capital [13] - Lian Technology's supervisory board chairman plans to reduce his holdings by up to 7,500 shares, representing 0.013% of the total share capital [14] - Guomai Culture's vice president plans to reduce his holdings by up to 5,050 shares, which is 0.05% of the total share capital [15] - Xiangfenghua's general manager plans to reduce his holdings by up to 25,000 shares, equating to 0.02% of the total share capital [16] Group 3 - Jintian International announced it won a bid for the intelligent upgrade project of the warehouse for China General Nuclear Power Group, with a contract value of 22 million yuan, representing 0.93% of the company's projected revenue for 2024 [18]
晚间公告丨6月15日这些公告有看头
Di Yi Cai Jing·2025-06-15 11:15